cinacalcet
cinacalcet is a pharmaceutical drug with 44 clinical trials. Currently 2 active trials ongoing. Historical success rate of 92.5%.
Success Metrics
Based on 37 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
11
Mid Stage
25
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.2%
37 of 41 finished
9.8%
4 ended early
2
trials recruiting
44
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of a Cincalcet Suppression Test
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Novel Combination Therapy for Osteoporosis in Men
A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Clinical Trials (44)
Evaluation of a Cincalcet Suppression Test
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Novel Combination Therapy for Osteoporosis in Men
A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular Hemodialysis
A Study of SHR6508 in Secondary Hyperparathyroidism
Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
Renal Osteodystrophy: An Individual Management Approach
E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Calcimimetics in Hypophosphatemic Rickets
Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease
Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 44